Aktie VSBC VITASPRING BIOMEDICAL CO. LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen VitaSpring Biomedical Co. Ltd.

Aktien

VSBC

US92851B1026

VSBC

Markt geschlossen - OTC Markets
Andere Börsenplätze
 20:03:41 11.08.2023 		% 5 Tage % 1. Jan.
15 USD +36,24 % Intraday Chart für VitaSpring Biomedical Co. Ltd. -.--% -.--%
2022 VitaSpring Biomedical Co. Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Oktober 2022 CI
2022 VitaSpring Biomedical Co. Ltd. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Juli 2022 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
VITASPRING BIOMEDICAL CO. LTD. : Changes in Registrant's Certifying Accountant (form 8-K)
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2022
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Full Year Ended January 31, 2022
VitaSpring Biomedical Co. Ltd. Auditor Raises 'Going Concern' Doubt
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021
QuantuMDx Group Limited announced that it has received ?15 million in funding from VitaSpring Biomedical Co. Ltd.
VITASPRING BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter Ended July 31, 2021
VITASPRING BIOMEDICAL CO. LTD. : Change in Directors or Principal Officers (form 8-K)
Vitaspring Biomedical Co. Ltd. Announces Management Changes
VITASPRING BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2021
VITASPRING BIOMEDICAL CO. LTD. : Unregistered Sale of Equity Securities (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. VSBC Aktie
  4. Nachrichten VitaSpring Biomedical Co. Ltd.
  5. Andere Sprachen